Hydroxychloroquine and tocilizumab therapy in COVID-19 patients—An observational study
Andrew Ip(Hackensack University Medical Center), Stuart L. Goldberg(Center for Discovery), Bindu Balani(Association Clinique et Thérapeutique Infantile du Val de Marne), Eric Hansen, Carol L. Barsky(Hackensack Meridian Health), Brittany Sinclaire(Hackensack University Medical Center), Joseph P. Underwood(Hackensack University Medical Center), Scott Berry(Queen's University), Ronaldo C. Go, Andrew L. Pecora(Hackensack University Medical Center), Shivam Mathura, Rani Sebti(Hackensack Meridian Health), Jason Korcak(Hackensack Meridian Health), Noa Biran(Hackensack University Medical Center), Steven M. Sperber(Hackensack Meridian Health), Jerry M. Zuckerman(Hackensack Meridian Health), Michael Marafelias(Hackensack University Medical Center), Julia A Piwoz(Children's Hospital at Montefiore), Joseph Landolfi(Hackensack Meridian Health), Sarah Timmapuri(Hackensack Meridian Health), Donald A. Berry(Berry & Associates (United States)), Lisa Tank(Hackensack Meridian Health), Nicholas Berry(Berry & Associates (United States)), Arif Asif(New York City Health and Hospitals Corporation), Urszula Bednarz(Hackensack University Medical Center), Keith Rose, Laurie G. Jacobs(Hackensack Meridian Health), André Goy(Hackensack University Medical Center), Dániel Varga(Hackensack Meridian Health), Gregory Sugalski(Hackensack Meridian Health), Cristina Cicogna(Hackensack Meridian Health), Ihor S. Sawczuk
Cited by 144
Related Papers
Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis
|JAMA|2019|1.5k
Revision of the American Joint Committee on Cancer Staging System for Breast Cancer
|Journal of Clinical Oncology|2002|1.2k
Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation
|JAMA|2010|1.2k
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
|Nature Medicine|2015|1.1k
Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke
|New England Journal of Medicine|2013|980